Uncategorized
AGTC earns Innovator Award at OIS
CHICAGO — Applied Genetic Technologies Corp. was awarded with the Innovator Award here at the Ophthalmology Innovation Summit, ahead of the American Academy of Ophthalmology annual meeting. The clinical-stage biotechnology company has developed adeno-associated virus-based gene therapies for X-linked retinoschisis, achromatopsia and X-linked retinitis pigmentosa.